Shree Ganesh Biotech India Ltd

Shree Ganesh Biotech India has reached a new 52-week low of Rs.0.58, marking a significant decline in its stock price amid subdued financial performance and challenging market conditions within the Pharmaceuticals & Biotechnology sector.

Shree Ganesh Biotech India has reached a new 52-week low of Rs.0.58, marking a significant decline in its stock price amid broader market gains. The stock's performance contrasts sharply with the positive momentum seen in the Sensex and the Pharmaceuticals & Biotechnology sector.

Shree Ganesh Biotech India has reached a new 52-week low, closing at Rs.0.58 today, marking a significant decline in its stock price amid a challenging year for the company within the Pharmaceuticals & Biotechnology sector.

Shree Ganesh Biotech India has reached a new all-time low price of Rs.0.58, marking a significant milestone in its ongoing decline. The stock's performance continues to lag behind both its sector and the broader market, reflecting persistent pressures within the Pharmaceuticals & Biotechnology industry.

Shree Ganesh Biotech India has reached a new 52-week low, with its share price touching Rs.0.61 today. This significant price level marks a continuation of the stock’s subdued performance over the past year, contrasting with broader market gains.

Shree Ganesh Biotech India has reached a new 52-week low, with its share price touching Rs.0.61 today. This marks a significant decline from its 52-week high of Rs.1.19, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector despite a broadly positive market environment.

Shree Ganesh Biotech India has reached a new all-time low price of ₹0.62, marking a significant milestone in its ongoing decline. The stock’s performance over multiple time frames reveals a persistent downward trajectory, contrasting sharply with broader market gains.

Shree Ganesh Biotech India has reached a new all-time low price of Rs.0.62, marking a significant milestone in its extended period of decline. The stock's performance over multiple time frames reflects persistent challenges within the Pharmaceuticals & Biotechnology sector, contrasting sharply with broader market trends.

Shares of Shree Ganesh Biotech India have reached an all-time low, reflecting a sustained period of subdued performance within the Pharmaceuticals & Biotechnology sector. The stock’s recent price movements and financial indicators highlight the severity of the company’s current position in the market.

Shares of Shree Ganesh Biotech India have declined to a fresh 52-week low of Rs.0.62, marking a significant price level for the pharmaceutical and biotechnology company amid a challenging market environment.

Shree Ganesh Biotech India’s stock reached a new 52-week low of Rs.0.62 today, marking a significant decline amid broader market gains. The stock’s performance contrasts sharply with sector and benchmark indices, reflecting ongoing pressures within the company’s financial and operational metrics.

Shree Ganesh Biotech India has reached a new 52-week low, with its share price touching Rs.0.62 today. This marks a significant decline from its 52-week high of Rs.1.19, reflecting ongoing pressures within the Pharmaceuticals & Biotechnology sector and the company’s financial performance over the past year.

Shree Ganesh Biotech India has reached a new 52-week low of Rs.0.62, marking a significant decline in its stock price amid subdued financial performance and challenging market conditions within the Pharmaceuticals & Biotechnology sector.

Shree Ganesh Biotech India has reached a new all-time low of Rs.0.64, marking a significant milestone in its ongoing decline. The stock’s performance over multiple time frames reveals a sustained downward trajectory, contrasting sharply with broader market gains and sector trends.

Shree Ganesh Biotech India has reached a new 52-week low, with its share price touching Rs.0.64 today. This marks a significant decline for the pharmaceutical and biotechnology company amid a broader market environment where the Sensex continues to show resilience.

Shree Ganesh Biotech India has reached a new 52-week low, with its share price touching Rs.0.64 today. This marks a significant decline for the pharmaceutical and biotechnology company amid a broader market environment where the Sensex continues to show resilience.

Shree Ganesh Biotech India has reached a new 52-week low, with its share price touching Rs.0.64 today. This marks a significant decline for the pharmaceutical and biotechnology company amid a broader market environment where the Sensex continues to show resilience.

Shree Ganesh Biotech India has reached an all-time low in its stock price, reflecting a sustained period of subdued performance within the Pharmaceuticals & Biotechnology sector. The stock’s recent movements and financial indicators highlight the severity of the challenges faced by the company over multiple time horizons.